Relationship between Antidepressant Prescription Rates and Features of Schizophrenic Patients and Its Outcome in Schizophrenia Treatment

Hanci N., Eker O. C., Miraloglu O., Uslu M. A., ÖZKAYA G., EKER S. S.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, vol.52, no.1, pp.64-68, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 52 Issue: 1
  • Publication Date: 2015
  • Doi Number: 10.5152/npa.2015.7041
  • Journal Name: NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.64-68
  • Keywords: Schizophrenia, depression, antidepressant, PLACEBO-CONTROLLED TRIAL, DOUBLE-BLIND, DEPRESSIVE SYNDROMES, NEGATIVE SYMPTOMS, SERTRALINE, EFFICACY, SUICIDE, OUTPATIENTS, DISORDERS, EPISODE
  • Bursa Uludag University Affiliated: Yes

Abstract

Introduction: Comorbid depression in schizophrenia is associated with poor outcome, increased risk of relapse and a high rate of suicide. Identification of depressive symptoms and their appropriate treatment is crucial for depressed schizophrenic patients. The aim of this study is to investigate the rates of antidepressant prescription and their outcomes.